1. Home
  2. ANIP vs AIV Comparison

ANIP vs AIV Comparison

Compare ANIP & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • AIV
  • Stock Information
  • Founded
  • ANIP 2001
  • AIV 1975
  • Country
  • ANIP United States
  • AIV United States
  • Employees
  • ANIP N/A
  • AIV N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • AIV Real Estate Investment Trusts
  • Sector
  • ANIP Health Care
  • AIV Real Estate
  • Exchange
  • ANIP Nasdaq
  • AIV Nasdaq
  • Market Cap
  • ANIP 1.2B
  • AIV 1.2B
  • IPO Year
  • ANIP N/A
  • AIV 1994
  • Fundamental
  • Price
  • ANIP $68.02
  • AIV $8.85
  • Analyst Decision
  • ANIP Strong Buy
  • AIV
  • Analyst Count
  • ANIP 8
  • AIV 0
  • Target Price
  • ANIP $79.75
  • AIV N/A
  • AVG Volume (30 Days)
  • ANIP 361.8K
  • AIV 876.0K
  • Earning Date
  • ANIP 05-09-2025
  • AIV 05-07-2025
  • Dividend Yield
  • ANIP N/A
  • AIV 6.84%
  • EPS Growth
  • ANIP N/A
  • AIV N/A
  • EPS
  • ANIP N/A
  • AIV N/A
  • Revenue
  • ANIP $614,376,000.00
  • AIV $208,679,000.00
  • Revenue This Year
  • ANIP $27.62
  • AIV $6.96
  • Revenue Next Year
  • ANIP $7.71
  • AIV N/A
  • P/E Ratio
  • ANIP N/A
  • AIV N/A
  • Revenue Growth
  • ANIP 26.20
  • AIV 11.60
  • 52 Week Low
  • ANIP $52.50
  • AIV $7.68
  • 52 Week High
  • ANIP $70.00
  • AIV $9.49
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 66.14
  • AIV 53.63
  • Support Level
  • ANIP $65.28
  • AIV $8.47
  • Resistance Level
  • ANIP $69.33
  • AIV $8.78
  • Average True Range (ATR)
  • ANIP 2.32
  • AIV 0.16
  • MACD
  • ANIP 0.29
  • AIV 0.02
  • Stochastic Oscillator
  • ANIP 83.54
  • AIV 79.17

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

Share on Social Networks: